The EMA at 20: Independence and transparency are the key to fulfilling the EMA's public health commitments
This article was originally published in Scrip
The EMA is ahead of the curve in addressing the concerns of patients, consumers and health professionals, but when it comes to independence, transparency and stimulating innovation, the agency still has a long way to go, say Tim Reed and Ancel.la Santos Quintano of Health Action International.
You may also be interested in...
A new coronavirus test template developed by the US Centers for Disease Control and Prevention is being refined by the agency so it can be shared with domestic and international partners to help identify more cases of the virus. In the meantime, state labs can use the posted assay for coronavirus on the CDC’s website for testing of residents within their jurisdiction and send results to the CDC.
The pharmaceutical industry will be watching carefully as the EU Court of Justice deliberates on whether to deny or widen the granting of supplementary protection certificates on new therapeutic indications of authorized medicines.
Dr Reddy’s Laboratories reported an unexpected third-quarter consolidated net loss after taking a $156m charge related to its generic version of the NuvaRing contraceptive. However, the company’s shares jumped on a robust underlying performance that was praised by analysts.